نتائج البحث

1

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial

المؤلفون: Frank A. Sinicrope, Qian Shi, Aurelie Catteau, Graham M. Poage, Tyler J. Zemla, Bernhard Mlecnik, Al B. Benson, Sharlene Gill, Richard M. Goldberg, Morton S. Kahlenberg, Suresh G. Nair, Anthony F. Shields, Thomas C. Smyrk, Jerome Galon, Steven R. Alberts

المصدر: JCO Precision Oncology.

مصطلحات موضوعية: Oxaliplatin, Cancer Research, Organoplatinum Compounds, Oncology, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Colonic Neoplasms, Leucovorin, Humans, Fluorouracil, Prognosis, Neoplasm Staging

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed77c7c833d4abdc93a928c901640b00Test
https://doi.org/10.1200/po.22.00010Test

2

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

المؤلفون: Al B. Benson, Hong Li, Heinz-Josef Lenz, Daniel G. Haller, Carlos Robles, Rachel E. Sanborn, Motomi Mori, Charles D. Blanke, Nora Mattek, Tomislav Dragovich, Emerson Y. Chen, Charles D. Lopez

المصدر: American Journal of Clinical Oncology. 41:1193-1198

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ae101b6cdab9ede4c429bbed014300Test
https://doi.org/10.1097/coc.0000000000000465Test

3

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

المصدر: J Clin Oncol

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc68869d7b7f5e0c8806cfc0e06adedTest
https://europepmc.org/articles/PMC7406334Test/

4

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group Trial (E3205)

المؤلفون: Mary F. Mulcahy, Joseph A. Sparano, Joel M. Palefsky, Karin I. Armstrong, Adedayo A. Onitilo, Richard Whittington, Edith P. Mitchell, Madhur Garg, Al B. Benson, Bassel F. El-Rayes, Shalom Kalnicki, Nassim H. Nabbout, Fengmin Zhao, Daniel J. Moriarty, Thomas J. Fitzgerald

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 35, iss 7

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Cetuximab, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Cancer, Chemoradiotherapy, Middle Aged, Anal canal, Anus Neoplasms, Primary tumor, 6.5 Radiotherapy and other non-invasive therapies, Survival Rate, medicine.anatomical_structure, Fluorouracil, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Immunocompetence, medicine.drug, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Disease-Free Survival, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Carcinoma, Humans, Oncology & Carcinogenesis, Survival rate, Aged, Neoplasm Staging, business.industry, Evaluation of treatments and therapeutic interventions, medicine.disease, Radiation therapy, 030104 developmental biology, Squamous Cell, Cisplatin, Digestive Diseases, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303dceb52cdab112d34dd89f6d253418Test
https://doi.org/10.1200/jco.2016.69.1667Test

5

BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer

المؤلفون: Al B. Benson, John Bridgewater, Igor Kiss, Jihong Chen, Carolyn Sasse, Sandra Vossen, Andrew Krivoshik, Ferry A.L.M. Eskens, Howard A. Ball, Anne Keating, Charles Van Sant

المساهمون: Medical Oncology

المصدر: Clinical Cancer Research, 22(20), 5058-5067. American Association for Cancer Research Inc.

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Tivozanib, Bevacizumab, Population, Leucovorin, Angiogenesis Inhibitors, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Clinical endpoint, Humans, education, education.field_of_study, business.industry, Phenylurea Compounds, Middle Aged, Interim analysis, Neuropilin-1, Surgery, Receptors, Vascular Endothelial Growth Factor, 030104 developmental biology, Tolerability, Fluorouracil, 030220 oncology & carcinogenesis, Disease Progression, Quinolines, Female, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95348a748c8bc3cf7c06f595f725f03Test
https://doi.org/10.1158/1078-0432.ccr-15-3117Test

6

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

المؤلفون: Alan P. Venook, Donna Niedzwiecki, Robert J. Mayer, Xing Ye, Victoria M. Villaflor, David H. Ilson, Peter C. Enzinger, Al B. Benson, Barbara Burtness, Steven J. Cohen, Kathe Douglas, Richard M. Goldberg

المصدر: Journal of Clinical Oncology. 34:2736-2742

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Esophageal Neoplasms, Organoplatinum Compounds, Leucovorin, Cetuximab, Phases of clinical research, Antineoplastic Agents, Adenocarcinoma, Irinotecan, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, FOLFOX, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Treatment Failure, Survival rate, Aged, Epirubicin, Aged, 80 and over, business.industry, Middle Aged, digestive system diseases, Oxaliplatin, Survival Rate, 030104 developmental biology, Fluorouracil, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Disease Progression, Camptothecin, Female, Esophagogastric Junction, Cisplatin, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::404ece68128fde081d9e5b6e38369f13Test
https://doi.org/10.1200/jco.2015.65.5092Test

7

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)

المصدر: Oncologist

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded464c4b4064218df454808e97022fcTest
https://pubmed.ncbi.nlm.nih.gov/31852811Test

8

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)

المؤلفون: Antonio Jimeno, Mary F. Mulcahy, Al B. Benson, M. K. Gibson, Elizabeth A. Montgomery, Lawrence Leichman, Lawrence Kleinberg, Wei Frank Song, Paul J. Catalano, Charles A. Staley

المصدر: The oncologist. 25(1)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, Phases of clinical research, Cetuximab, Docetaxel, Adenocarcinoma, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Cancer, medicine, Humans, Postoperative Period, Aged, Chemotherapy, business.industry, Middle Aged, medicine.disease, Oxaliplatin, Regimen, 030104 developmental biology, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Preoperative Period, Female, Fluorouracil, business, Progressive disease, Chemoradiotherapy, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0204bb444e2ace81e6a5c96f899293d6Test
https://pubmed.ncbi.nlm.nih.gov/31227647Test

9

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

المصدر: JAMA Oncology. 6:1571

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307744b05b8ada35ac13a191f4191ecfTest
https://doi.org/10.1001/jamaoncol.2020.3370Test

10

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

المؤلفون: Kathleen D. Danenberg, Christine Cripps, James A. Martensen, Robert J. Mayer, Thomas Winder, Tyvin A. Rich, Stephen R. Smalley, Wu Zhang, Al B. Benson, Heinz-Josef Lenz, Jacqueline Benedetti, Cathryn Rankin, Charles D. Blanke, Pierre Oliver Bohanes, Karen W. Makar, Cornelia M. Ulrich

المساهمون: University of Zurich, Lenz, Heinz-Josef

المصدر: Clinical Cancer Research. 21:1583-1590

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Genotype, Colorectal cancer, medicine.medical_treatment, 610 Medicine & health, Antineoplastic Agents, Kaplan-Meier Estimate, Lower risk, Polymorphism, Single Nucleotide, Gastroenterology, Article, Disease-Free Survival, Young Adult, Internal medicine, medicine, Mucositis, Humans, 1306 Cancer Research, Aged, Aged, 80 and over, Rectal Neoplasms, Reverse Transcriptase Polymerase Chain Reaction, business.industry, Chemoradiotherapy, Middle Aged, Prognosis, medicine.disease, Surgery, Radiation therapy, Glutathione S-Transferase pi, Oncology, Fluorouracil, Concomitant, 10032 Clinic for Oncology and Hematology, 2730 Oncology, Female, ERCC1, business, Polymorphism, Restriction Fragment Length, medicine.drug

وصف الملف: 1583.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::921456dcc8e00fbbd1ea27cb22d95015Test
https://doi.org/10.1158/1078-0432.ccr-14-0857Test

تنقيح النتائج